NEW YORK (GenomeWeb News) – Thermo Fisher Scientific announced today that it has completed its tender offer for Dionex and expects to complete its purchase of the chromatography firm through a short-form merger later this week.
As of the expiration of the offer last Friday and based on preliminary information, more than 16 million shares were tendered and not withdrawn in the tender offer, representing 93 percent of Dionex's issued and outstanding shares.